Review Article

TAVR: A Review of Current Practices and Considerations in Low-Risk Patients

Table 4

Comparison of outcomes between TAVR and SAVR patients in Low-Risk TAVR Trials.

PARTNER IIIEvolut Low-RiskNOTION

All-cause and CV-mortality at 1 yearTAVR: 1.0 %TAVR: 2.4%TAVR: 4.9%
SAVR: 2.5%SAVR: 3.0%SAVR: 7.5%

Disabling stroke at 1 yearTAVR: 0.2%TAVR: 0.8%
SAVR: 0.9%SAVR: 2.4%TAVR: 2.9%
Nondisabling stroke at 1 yearTAVR: 1.0%TAVR: 3.4%SAVR: 4.6%
SAVR: 2.2%SAVR: 2.2%

TIA at 1 yearTAVR: 1.0%TAVR: 1.7%TAVR: 2.1%
SAVR: 1.1%SAVR: 1.8%SAVR: 1.6%

Major vascular complications at 30 daysTAVR: 2.2%TAVR: 3.8%TAVR: 5.6%
SAVR: 1.5%SAVR: 3.2%SAVR: 1.5%

AKI (stage II or III) (in 30 days)TAVR: 0.4%TAVR: 0.9%TAVR: 0.7%
SAVR: 1.8%SAVR: 2.8%SAVR: 6.7%

New-onset AF (at 1 year)TAVR: 7.0%TAVR: 9.8%TAVR: 21.2%
SAVR: 40.9%SAVR: 38.3%SAVR: 59.4%

New PPM implantation at 1 yearTAVR: 7.5%TAVR: 19.4%TAVR: 38.0%
SAVR: 5.5%SAVR: 6.7%SAVR: 2.4%

Coronary artery obstruction requiring intervention at 1 yearTAVR: 0.2%TAVR: 0.9%No TAVR-treated patient required PCI during the procedure; 1 SAVR patient required concomitant coronary artery bypass resulting from a right coronary ostium lesion
SAVR: 0.7%SAVR: 0.4%

MI at 1 yearTAVR: 1.2%TAVR: 1.7%TAVR: 3.5%
SAVR: 2.2%SAVR: 1.6%SAVR: 6.0%

Valve thrombosis at 1 yearTAVR: 1.0%TAVR: 0.2%Not reported
SAVR: 0.2%SAVR: 0.3%

PVL (≥moderate) at 1 yearTAVR: 0.6%TAVR: 3.5%TAVR: 15.7%
SAVR: 0.5%SAVR: 0.5%SAVR: 17.7%

Patient-prosthesis mismatch (30 days)TAVR moderate: 29.8%TAVR moderate: 5.0%Not reported
SAVR moderate: 23.3%SAVR moderate: 15.7%
TAVR severe: 4.3%TAVR severe: 1.8%
SAVR severe: 6.3%SAVR severe: 8.2%

Rehospitalization at 1 year (valve or procedure related, including CHF)TAVR: 7.3%TAVR: 3.2%Not reported
SAVR: 11.0%SAVR: 6.5% (CHF rehospitalization only)

AF = atrial fibrillation; AKI = acute kidney injury; CHF = congestive heart failure; CV = cardiovascular; MI = myocardial infarction; PCI = percutaneous coronary intervention; PPM = permanent pacemaker; PVL = paravalvular leak; TIA = transient ischemic attack. Although NOTION studied patients of all surgical risks; 81.8% of patients were considered low-risk (STS<4%).